Publications by authors named "Ivan Cheglakov"

Claim this Profile
C
Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
Lyudmila S Krassikova, Saida S Karshieva, Ivan B Cheglakov, Alexander V Belyavsky

J Gene Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripherally Applied Synthetic Tetrapeptides HAEE and RADD Slow Down the Development of Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice.
Philipp O Tsvetkov, Ivan B Cheglakov, Armen A Ovsepyan, Oleg Y Mediannikov, Alexander O Morozov

J Alzheimers Dis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice.
Alexandra A Kulikova, Ivan B Cheglakov, Michail S Kukharsky, Ruslan K Ovchinnikov, Sergey A Kozin

Neurotox Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripherally applied synthetic tetrapeptides HAEE and RADD slow down the development of cerebral β-amyloidosis in AβPP/PS1 transgenic mice.
Philipp O Tsvetkov, Ivan B Cheglakov, Armen A Ovsepyan, Oleg Y Mediannikov, Alexander O Morozov

J Alzheimers Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin alpha5beta1 controls invasion of human breast carcinoma cells by direct and indirect modulation of MMP-2 collagenase activity.
Galina Morozevich, Nadezda Kozlova, Ivan Cheglakov, Natalia Ushakova, Albert Berman

Cell Cycle· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis